Mainz Biomed N.V.
MYNZ
$4.73
-$0.16-3.27%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/13/2025
-
GuruFocus
3/13/2025
-
The Fly
3/13/2025
-
Globe Newswire
3/7/2025
-
Stocktwits News Feed
3/3/2025
-
GuruFocus
3/3/2025
-
TipRanks Financial Blog
3/3/2025
-
The Fly
3/3/2025
-
Globe Newswire
2/20/2025
-
GuruFocus
2/20/2025
-
Seeking Alpha - Healthcare
2/20/2025
-
SeekingAlpha.com: All News
2/20/2025
-
The Fly
2/20/2025
-
Globe Newswire
2/15/2025
-
GuruFocus
2/14/2025
-
The Fly
2/14/2025
-
The Fly
2/11/2025
-
GuruFocus
2/11/2025
-
The Fly
2/11/2025
-
Globe Newswire
1/27/2025
-
GuruFocus
1/27/2025
-
Seeking Alpha - Healthcare
1/27/2025
-
The Fly
1/27/2025
-
Globe Newswire
1/21/2025
-
GuruFocus
1/21/2025
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, April 9, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Week of Apr 7 and 11 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
49 6131 554 2860
Address
Robert Koch Strasse 50
Mainz, 55129
Mainz, 55129
Country
Year Founded
Business Description
Sector
Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular...
more
